Clinical Trial Update: Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab [Phase 4]

View source ↗

Summary

Phase 4 study evaluating how plasma exchange affects the pharmacokinetics of rituximab in renal transplant recipients and patients with autoimmune diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Renal Transplantation

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Renal Transplant, Autoimmune Diseases | Phase 4 | Status: COMPLETED